MPS is absolutely contraindicated in pregnant or breastfeeding patients, acute myocardial infarction (<2 days), acute myocarditis, acute pulmonary embolism, acute aortic dissection, acute symptomatic medical illness (such as metastatic cancer), severe symptomatic aortic stenosis, severe pulmonary artery hypertension, high-risk unstable angina, congestive heart failure, severe hypertension (>200/110 mmHg) and sustained cardiac arrhythmias.

MPS is relatively contraindicated in patients with significant left main coronary artery disease, asymptomatic severe aortic stenosis (mean gradient > 40 mmHg, aortic valve area < 1cmsq, aortic jet velocity > 4 m/sec), hypertrophic obstructive cardiomyopathy, or forms of severe left ventricular outflow obstruction, complete heart block.